AMS (American Medical Systems) prices convertible debt offering:
This article was originally published in Clinica
American Medical Systems (AMS) last week priced $325m worth of convertible senior subordinated notes that will mature in 2036. The notes will be convertible either into cash or AMS shares, depending on the circumstances, said the Minneapolis, Minnesota company. The firm plans to use the net proceeds from the offering to fund part of its proposed $715m purchase of San Jose, California-based Laserscope (see Clinica No 1209, p 16), as well as for general working capital purposes. Should the Laserscope transaction fall through, AMS said it would use the proceeds for other possible acquisitions.